18 Jan TreeFrog Therapeutics
Myriam Makhloufi, Chief Strategy Officer
April 15 | 5:15pm | Salone dei Cavalieri, Section 2
Pessac, France
(Private)
TreeFrog Therapeutics is a regenerative medicine biotech set to unlock access to cell therapies for millions of patients. TreeFrog is unique in its approach to cell therapy development bringing together biophysicists, cell biologists and bioproduction engineers to address the challenges of the industry – producing and differentiating cells of quality at unprecedented scale, cost-effectively. To realize their mission of Cell Therapy for all, TreeFrog operates a business model that includes its own therapeutic programs and partnerships with leading biotech and industry players based on their proprietary platform technology, C-Stem™. In the last 3 years, the company has raised $82 million to advance a pipeline of stem cell-based therapies in regenerative medicine. Headquartered in Pessac, France, the company has a technological hub in Boston, USA to drive the adoption of the platform and establish strategic alliances with leading academic, biotech and industry players.
